Terrance Gluth, the owner of this newspaper and New Newmanton's only billionaire, released a 67-page manifesto Tuesday addressing mNRA vaccine technology, the participation of transgender women in competitive lacrosse, and a condition he has named "chronic vaccine treatment," which he describes in the document's executive summary as "the thing that is happening." The New Newmanton News announced the same day that it will publish the manifesto in its entirety, unedited, across Thursday's print and digital editions. Editor-in-Chief Robert Haas, in an internal memo reviewed by this reporter, cited Gluth's net worth as "the clearest available signal of domain expertise" and noted that the paper's style guide "has never required a degree in the relevant field, only sufficient certainty."

Gluth, whose formal academic credential is an MBA in Real Estate from the University of Minnesota's correspondence program — the same institution whose researchers recently identified 16,847 references to this paper's staff in federal documents, as The News reported — completed the manifesto over what a spokesperson described as "an intensive fourteen-day research period." The document draws on seventeen sources, four of which are the manifesto itself, cited prospectively. The lacrosse section, which runs to nineteen pages and constitutes the document's longest chapter, includes three original diagrams and a proposal for a governing body Gluth calls the "Honest Athletics Legitimacy League," or HALL. The acronym is used 38 times before it is introduced.

The paper's parent entity, Consolidated Finality Partners LLC, issued a one-paragraph statement reading in part: "The New Newmanton News has always believed that access to information is a public good, and that the most important information comes from people with the most to lose if they are wrong, which Mr. Gluth, given his net worth, is not." The statement did not address what mNRA stands for. Neither did the manifesto, in 67 pages.

The full text will appear in Thursday's edition beginning on page one and concluding, the paper confirmed, wherever it concludes.